sorafenib has been researched along with apigenin in 3 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (apigenin) | Trials (apigenin) | Recent Studies (post-2010) (apigenin) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 3,273 | 75 | 2,086 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
Dodurga, Y; Elmas, L; Seçme, M; Şirin, N | 1 |
Akhtar, K; Arjmand, F; Khan, MA; Siddique, HR; Singh, D | 1 |
1 review(s) available for sorafenib and apigenin
Article | Year |
---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
2 other study(ies) available for sorafenib and apigenin
Article | Year |
---|---|
Investigation of possible effects of apigenin, sorafenib and combined applications on apoptosis and cell cycle in hepatocellular cancer cells.
Topics: Apigenin; Apoptosis; Cell Cycle; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Sorafenib | 2020 |
Apigenin alleviates cancer drug Sorafenib induced multiple toxic effects in Swiss albino mice via anti-oxidative stress.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apigenin; Apoptosis; Humans; Mice; Neoplasms; Oxidative Stress; Sorafenib | 2022 |